| Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants S Feng, UD Ekong, SJ Lobritto, AJ Demetris, JP Roberts, P Rosenthal, ... Jama 307 (3), 283-293, 2012 | 373 | 2012 |
| Anti-angiotensin II type 1 receptor and anti-endothelial cell antibodies: a cross-sectional analysis of pathological findings in allograft biopsies MC Philogene, S Bagnasco, ES Kraus, RA Montgomery, D Dragun, ... Transplantation 101 (3), 608-615, 2017 | 78 | 2017 |
| Differential effect of bortezomib on HLA class I and class II antibody MC Philogene, P Sikorski, RA Montgomery, MS Leffell, AA Zachary Transplantation 98 (6), 660-665, 2014 | 57 | 2014 |
| Antibodies against angiotensin II type 1 and endothelin A receptors: relevance and pathogenicity MC Philogene, T Johnson, AJ Vaught, S Zakaria, N Fedarko Human immunology 80 (8), 561-567, 2019 | 54 | 2019 |
| Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study MK Jang, I Tunc, GJ Berry, C Marboe, H Kong, MB Keller, PD Shah, ... The Journal of Heart and Lung Transplantation 40 (8), 822-830, 2021 | 50 | 2021 |
| Pre-transplant screening for non-HLA antibodies: who should be tested? MC Philogene, S Zhou, BE Lonze, S Bagnasco, S Alasfar, ... Human immunology 79 (4), 195-202, 2018 | 43 | 2018 |
| Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis MC Philogene, A Amin, S Zhou, O Charnaya, R Vega, N Desai, AM Neu, ... Pediatric nephrology 35, 83-94, 2020 | 26 | 2020 |
| Non-HLA antibodies in transplantation: when do they matter? MC Philogene, AM Jackson Current Opinion in Organ Transplantation 21 (4), 427-432, 2016 | 25 | 2016 |
| Pathogenic consequences of Neisseria gonorrhoeae pilin glycan variation SK Ghosh, J Zhao, MC Philogene, A Alzaharani, S Rane, A Banerjee Microbes and infection 6 (7), 693-701, 2004 | 24 | 2004 |
| Histopathologic changes in anti-angiotensin II type 1 receptor antibody-positive kidney transplant recipients with acute rejection and no donor specific HLA antibodies MA Lim, M Palmer, J Trofe-Clark, RD Bloom, A Jackson, MC Philogene, ... Human Immunology 78 (4), 350-356, 2017 | 19 | 2017 |
| Distinct Caenorhabditis elegans HLH‐8/twist‐containing dimers function in the mesoderm MC Philogene, SG Meyers Small, P Wang, AK Corsi Developmental Dynamics 241 (3), 481-492, 2012 | 13 | 2012 |
| Current donor selection strategies for allogeneic hematopoietic cell transplantation OA Timofeeva, MC Philogene, QJ Zhang Human Immunology 83 (10), 674-686, 2022 | 11 | 2022 |
| Clinical features and allograft failure rates of pulmonary antibody-mediated rejection categories AV Charya, IL Ponor, A Cochrane, D Levine, M Philogene, YP Fu, ... The Journal of Heart and Lung Transplantation 42 (2), 226-235, 2023 | 8 | 2023 |
| Eplet mismatches associated with de novo donor-specific HLA antibody in pediatric kidney transplant recipients O Charnaya, J Jones, MC Philogene, PY Chiang, DL Segev, AB Massie, ... Pediatric Nephrology 36 (12), 3971-3979, 2021 | 8 | 2021 |
| Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death M Keller, S Yang, L Ponor, A Bon, A Cochrane, M Philogene, E Bush, ... American Journal of Transplantation 23 (4), 559-564, 2023 | 7 | 2023 |
| Prevalence of angiotensin II type 1 receptor antibodies in persons with hypertension and relation to blood pressure and medication MC Philogene, D Han, F Alvarado, NS Fedarko, AB Zonderman, ... American Journal of Hypertension 33 (8), 734-740, 2020 | 5 | 2020 |
| Clinical and histological predictors of operational tolerance in pediatric liver transplant recipients S Feng, U Ekong, S Lobritto, A Demetris, P Rosenthal, E Alonso, D Ikle, ... American Journal of Transplantation 11, 76-76, 2011 | 5 | 2011 |
| Successful A2 to B Deceased Donor Kidney Transplant after Desensitization for High‐Strength Non‐HLA Antibody Made Possible by Utilizing a Hepatitis C Positive Donor HC Karpel, NM Ali, N Lawson, VS Tatapudi, R Friedlander, MC Philogene, ... Case Reports in Transplantation 2020 (1), 3591274, 2020 | 4 | 2020 |
| Presentation and Outcomes of Antibody-Mediated Rejection Associated With Angiotensin II Receptor 1 Antibodies Among Kidney Transplant Recipients M Abuzeineh, Y Kyeso, MC Philogene, N Alachkar, S Alasfar Transplantation proceedings 53 (5), 1501-1508, 2021 | 2 | 2021 |
| Correction to: Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis MC Philogene, A Amin, S Zhou, O Charnaya, R Vega, N Desai, AM Neu, ... Pediatric Nephrology (Berlin, Germany) 35 (4), 719, 2020 | 2 | 2020 |
